AHRQ seeks comments on acute pain treatment resource
The Agency for Healthcare Research and Quality is accepting comments through April 25 on a draft report on treatment for acute pain. The report provides an overview of current guidelines and systematic reviews on pharmacologic and nonpharmacologic treatments for acute pain, including opioids. The resource maps the current evidence on acute pain treatment for select conditions, including postoperative, dental, neck and back pain as well as renal colic, acute migraine and sickle cell crisis.
Related News Articles
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…